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Introduction
Microarray-based comparative genome hybridization
(array-CGH), also known as genomic microarrays [1],
is a genome-wide detecting method for imbalanced copy
number of DNA sequences [2–4]. Chromosomal alter-
ations can be detected by array-CGH directly, which in
turn help us understand the underlying pathophysiology
of several diseases such as cancers or congenital syn-
dromes. Nevertheless, the minimal amount of genomic
DNA required for hybridization of genomic microarray
is about 2–4 µg, and such a DNA amount is still a 
challenge to obtain from some clinical specimens, such
as formalin-embedded tissues, embryo biopsy for preim-
plantation genetic diagnosis, sperm or oocyte typing, or
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SUMMARY
Objective: Whole genome amplification (WGA) is a crucial procedure for genomic DNA analysis from limited
sources, such as in forensic analysis, embryo biopsy for preimplantation genetic diagnosis, or needle aspiration
biopsies. Several strategies for WGA have been developed for either genotyping or microarray-based comparative
genome hybridization (array-CGH) during the past decade. Nevertheless, there were few studies in which various
WGA methods had been performed side-by-side and results evaluated with multiple methods.
Materials and Methods: Ease of performance, qualitative accuracy, and quantitative fidelity of different WGA
methods, such as degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR), ligation-mediated
PCR (LM-PCR) and strand displacement amplification (SDA), were compared in amplifying genomic DNA derived
from karyotype-confirmed amniocytes and the cancer cell line SAOS2.
Results: Using analysis with microsatellite markers, single nucleotide polymorphism markers, and array-CGH,
our results suggested that: (1) genomic DNA amplified from DOP-PCR resulted in false positive and negative
results by analysis with array-CGH; (2) SDA is the easiest performance method among the three WGA methods;
and (3) amplified DNA products generated by LM-PCR best reflect the original genomic DNA.
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needle aspiration biopsies [5,6]. The available amount
of genomic DNA from some clinical specimen is still a
limiting factor for genomic analysis with array-CGH.
To overcome the difficulty, several whole genome
amplification (WGA) methods have been developed
during the past decade, e.g. degenerate oligonucleotide-
primed polymerase chain reaction (DOP-PCR), ligation-
mediated polymerase chain reaction (LM-PCR), and
strand displacement amplification (SDA) [7]. Each of
them has been applied for single nucleotide polymor-
phism (SNP) analysis, genotyping for short tandem
repeat loci, array-CGH analysis, and chromatin immuno-
precipitation on chip assay [5,7–9]. Nevertheless, one
potential bias of the two thermocycling-based methods
(DOP-PCR and LM-PCR) is caused by uneven distribu-
tion of GC-rich regions in genomic DNA, which often
affects polymerase chain reaction (PCR) amplification
[7,10]. SDA is based on the ability of the polymerases,
ϕ29 DNA polymerase and the large fragment of Bacillus
stearothermophilus (Bst DNA polymerase, large fragment),
to cause strand displacement with random amplification
initiation points by using random primers [7,10]. Dis-
placed single strands are annealed by new random
priming events, and more DNA is generated to form a
network of hyperbranched DNA structures [7,10].
Among these WGA methods, SDA has been advocated
as the WGA method that possesses the most complete
genome coverage and minimal amplification bias [7,10].
However, there were few studies in which various WGA
methods had been performed side-by-side and results
evaluated with multiple methods.
In this study, we evaluated the ease of performance,
qualitative accuracy, and quantitative fidelity of DOP-
PCR, LM-PCR and SDA methods in amplifying genomic
DNA derived from karyotype-confirmed amniocytes and
a cancer cell line. By analysis with microsatellite markers,
SNP markers and array-CGH, we compared the effi-
ciency of these methods in representing amplified DNA.
Our results suggested that amplified DNA products gen-
erated by LM-PCR best reflect the original genomic DNA.
Materials and Methods
Genomic DNA extraction from amniocytes 
and human cell lines
Four genomic DNAs from three donors with known
cytogenetic diagnoses (G-banding) and one cancer cell
line were used in this study. Genomic DNA with 46,XY
was isolated from the peripheral blood of a normal male
volunteer, the deletion of 7q34 in a fetus was identified
with amniocentesis and chromosomal study in a 
pregnant woman with balanced translocation t(5;7)
(p15.3;q34), and a case of de novo inverted duplication
of chromosome 10q was diagnosed with both chro-
mosomal G-banding and conventional comparative
genome hybridization [11]. The human osteosarcoma
cell line, SAOS2, was obtained from the American Type
Culture Collection and cultured in DMEM-F12 medium
(Invitrogen, Carlsbad, CA, USA) supplemented with
10% fetal bovine serum, 100 units/mL of penicillin and
100 units/mL of streptomycin. Genomic DNA was
extracted using Puregene DNA isolation kit (Gentra
Systems; Qiagen, Valencia, CA, USA) according to the
manufacturer’s instructions. DNA concentration was es-
timated by spectrophotometry (GeneQuant; Amersham
Biosciences, Pittsburgh, PA, USA) and the DNA integrity
was confirmed by agarose gel electrophoresis.
Procedures of the three WGA methods
Before being subject to the whole genome amplifica-
tion procedures, each DNA specimen was diluted to
10 ng/µL with 10 mM Tris–HCl (pH 8.0) containing
0.1 mM EDTA. Ten nanograms of DNA input were used
in the following WGA experiments, except that 1 ng of
genomic DNA was tested in the SDA experiment.
DOP-PCR
The procedure of the DOP-PCR technique was similar
to that previously reported [12], with minor modifica-
tions. All thermal cycles were run on a PCR thermocycler
(GeneAmp System 9700; Applied Biosystems, Foster
City, CA, USA) in two steps. In the preamplification
step, 10 ng of both test and reference DNA were used
as a template in a 10 µL reaction mixture, which con-
tained 200 µM each of dTTP, dATP, dCTP and dGTP,
1 × Thermosequenase reaction buffer, 1 µM degenerate
oligonucleotide primer 5-CCGACTCGAGNNNNNNAT-
GTGG-3 (Integrated DNA technologies, USA), and
0.4 U/µL Thermosequenase (Amersham Biosciences,
Pittsburgh, PA, USA). The four initial cycles were per-
formed at low stringency conditions (denaturation at
94°C for 1 minute, annealing at 30°C for 1 minute, ramp
of 0.1°C/sec from 30°C to 72°C, extension at 72°C for
2 minutes, and a final extension of 10 minutes), followed
by 35 cycles at high stringency conditions (denaturation
at 95°C for 1 minute, annealing at 56°C for 1 minute,
extension at 72°C for 2 minutes, and a final extension
of 10 minutes). AmpliTaq Gold DNA polymerase
(Applied Biosystems, Foster City, CA, USA) was substi-
tuted with Thermosequenase in the second step.
LM-PCR
Adaptor ligation-mediated PCR was performed accord-
ing to a published protocol [13], with slight modifica-
tions. In brief, genome DNA was placed in a 55°C heating
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block for 10 minutes and digested with 10 U/µL of
MseI (New England Biolabs, Ipswich, MA, USA) for 3
hours at 37°C in a volume of 20 µL. After digestion, a
total of 25µL of ligation mixture was prepared on ice and
contained 4 mM of MseLig 12 (5-TAACTAGCATGC-
3), 4 µM of MseLig 21 (5-ATGGGGATTCCGCATGC-
TAGT-3) and 2.5 µL of 10 × T4 DNA ligase buffer, with
T4 DNA ligase (New England Biolabs, Ipswich, MA,
USA) being added last to prevent self-ligation of the
adaptor. In a thermal cycler, the mixture was incubated
at 16°C overnight, followed by 70°C for 20 minutes. The
volume of the resultant DNA ligation reaction product
was brought to 100 µL by adding deionized water. One-
tenth volume of the diluted ligated DNA sample was used
in the amplification PCR as previously described [13].
SDA
The procedure for the multiple SDA protocol was similar
to a previous report [14]. A reaction mixture (10 µL)
containing 100 µM of random primer with thio-
phosphate modification (5-NpNpNpNpNpsNpsN-3),
1 × ThermoPol buffer (New England Biolabs, Ipswich,
MA, USA) and 4% DMSO was denatured at 95°C
for 10 minutes and immediately transferred to ice for 
10 minutes. The reaction mixture was then brought to
a volume of 30 µL containing 400 µM of dNTPs, 30 ng/
µL of T4 gene 32 protein (G32P; Amersham Biosciences,
Pittsburgh, PA, USA) and large fragment Bst DNA
polymerase (New England Biolabs, Ipswich, MA, USA)
at 0.35 units/µL. Reactions were carried out at 50°C
for 6 hours. Amplification DNA solution was sonicated
with an ultrasonic processor (Misonix, Farmingdale,
NY, USA) that was adjusted to generate high output
(2 W) for 1-minute pulses. With this setting, DNA
fragments would be smaller than 1.5 Kb in size.
Analysis with microsatellite markers
Genotyping analysis was performed with ABI PRISM
Linkage Mapping Set version 2.5 (Applied Biosystems,
Foster City, CA, USA). For chromosome 7, we selected
18 markers: D7S493, D7S507, D7S515, D7S516,
D7S517, D7S519, D7S520, D7S531, D7S630, D7S636,
D7S657, D7S661, D7S669, D7S684, D7S798, D7S1870,
D7S2465, and D7S2476. For chromosome 8, nine
markers (D8S258, D8S260, D8S264, D8S272, D8S277,
D8S284, D8S285, D8S549, and D8S1784) were used.
SNP analysis with matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry (MALDI-
TOF) mass spectrometry (MS)
The sample preparation started with a PCR amplifica-
tion of genomic DNA containing 10 SNP sites. PCR
amplification was performed in a final volume of 10 µL
containing 20 ng of genomic or amplified DNA, 1 × PCR
buffer, 100 µM each of dTTP, dATP, dCTP and dGTP,
1 µM of each primer, and 1 U of Taq DNA polymerase,
following by 3 minutes’ denaturation at 95°C and 40
cycles of denaturation at 95°C for 30 seconds, anneal-
ing at melting temperature of each primer set for 30
seconds, extension at 72°C for 30 seconds, and final
extension at 72°C for 2 minutes. All thermal cycles were
run on a PCR machine (MJ Research, Watertown, MA,
USA). The PCR products were treated with magnetic
bead purification kit (Genopure ds; Bruker Daltonics,
Germany) to remove excess dNTPs and primers. All
purification steps were performed on the MAP II/8
robotic workstation (Bruker Daltonics, Germany).
The procedures for each primer extension reaction
and SNP analysis by MALDI-TOF MS (Autoflex; Bruker
Daltonics, Germany) were as previously reported [15].
DNA array-CGH
Genomic DNA were labeled following a protocol as
described by Pollack et al [2]. Two micrograms of sample
and reference (46,XX) genomic DNA were labeled with
Cy3 and Cy5-dCTP (NEN Life Science Products, Inc.,
Boston, MA, USA), respectively, using random primers.
The labeled probes were hybridized to a human cDNA
microarray (Genomic Medicine Research Core Labora-
tory [GMRCL] Human 15K) containing 15,000 sequence-
verified human cDNA clones that have been mapped to
12,530 different genes. Detailed information of GMRCL
Human 15K, accession number GPL5354, is available at
Gene Expression Omnibus (GEO; http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc = GPL5354). For
each pair of specimens, dye swapping was used for mini-
mizing labeling bias and statistical variances of data.
After hybridization and washing, the slides were
scanned with a confocal slide scanner, ChipReader
(Virtek, Ontario, Canada), to quantify fluorescence
intensities, and images were analyzed with GenePix 
Pro 4.1 software (Axon Instruments, Inc., CA, USA).
Data were normalized over the entire microarray by 
locally weighted linear regression (LOWESS) algo-
rithm, where changes of intensity were assumed to be
symmetric for all spots; thus, normalization was per-
formed in each bin of spots. Mapping information and
location of all clones were displayed by the order from
chromosome 1 to X according to the University of
California Santa Cruz genome browser (May 2004
freeze). To evaluate the statistical significance, we per-
formed the one-sample t test (null-hypothesis H0, µ = 0)
for each 50-gene window. The 50-gene windows were
then moved one gene by another along each chromo-
some. A p value of 0.001 was used as the threshold for
detecting significant gain or loss of genomic copy number.
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All data were calculated with MATLAB 6.5 software
(The MathWorks, Inc., MA, USA).
Results
Using 10 ng of genomic DNA as original input, the
amplicons for each method were about 0.3 to 4 Kb
from DOP-PCR, 0.2 to 2 Kb from LM-PCR, and 0.5 to
20 Kb from SDA, which were similar to previous reports
(Figure 1) [7]. The amplicon sizes, ease of perfor-
mance, and comparison of these three methods are
listed in Table 1. To examine if DNA amplification was
unbiased during experimental processing, 25 microsatel-
lite markers located on chromosomes 7 and 8 were
selected from ABI PRISM Linkage Mapping Set version
2.5 to compare four amplified DNAs with the result 
of original DNA (2 µg input). As showed in Figure 2,
some false negative or positive results were generated
during WGA, e.g. a loss of heterozygosity in genotyp-
ing for marker D7S517 was found in DOP-PCR ampli-
fied DNA that was inconsistent with the result of
original DNA (Figure 2). In accordance with the ratio
of false positive to negative results, the consistency
rate for each WGA method was 67% for DOP-PCR,
whereas LM-PCR and SDA showed almost similar con-
sistency rate (~ 90%). To examine the accuracy for
genotyping SNP after WGA, 10 randomly selected SNP
markers were genotyped by MALDI-TOF MS to com-
pare with the results from before and after amplifi-
cation of genomic DNA. The WGA DNA from each
method did not show any alterations (homozygosity
or heterozygosity) for SNP genotyping as compared
with their original DNAs (Figure 3 and Table 2).
To globally survey amplification fidelity of the 
three WGA methods, the WGA DNAs were applied for
1 2 3 4 M 1 2 3 4 M 1 2 3 4 M
2.2 Kb
0.5 Kb
DOP-PCR amplicon LM-PCR amplicon SDA amplicon
Figure 1. DNA products amplified by three methods of whole genome amplification were visualized on 1% agarose gel stained
with ethidium bromide. Lane 1: 46,XY; lane 2: 46,XX,7q34(−); lane 3: 46,XX,10q22(+); lane 4: SAOS2 osteosarcoma cell line;
M: λ-Hind III DNA marker. DOP-PCR = degenerate oligonucleotide-primed polymerase chain reaction; LM-PCR = ligation-
mediated polymerase chain reaction; SDA = strand displacement amplification.
Table 1. Comparison of three methods for whole genome amplification
DOP-PCR LM-PCR SDA
Pattern Thermal cycling Thermal cycling Isothermal
Product length 0.3–4 Kb 0.2–2 Kb 10–20 Kb
DNA polymerase (Pol) Thermosequenase and Roche Expand Long Template Bst polymerase
AmpliTaq PCR system
Error rate of Pol 1–3 × 10−4 4.8 × 10−6 1 × 10−4
Time required < 5 hr 2 days 5 hr
Input DNA
Reported 12.5 pg* Single cell (~ 6 pg)† 10 pg to 10 ng‡
Tested in this study 10 ng 10 ng 1 ng
Ease of performance Moderate Least easy Easiest
*As reported by Huang et al [12]; †as reported by Klein et al [13]; ‡as reported by Honoso et al [30]. DOP-PCR = degenerate oligonucleotide-primed polymerase
chain reaction; LM-PCR = ligation-mediated polymerase chain reaction; SDA = strand displacement amplification.
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Whole
genome
amplification
Original DNA
Loss of heterozygosity
Consistent
D7S517
249
255
249
249
255
Figure 2. (A) An allele dropout during whole genome 
amplification was detected as a loss of heterozygosity in geno-
typing with a microsatellite marker D7S517. (B) Genotyping
with 25 microsatellite markers on four DNA samples after
whole genome amplification with degenerate oligonucleotide-
primed polymerase chain reaction (DOP-PCR), ligation-
mediated polymerase chain reaction (LM-PCR) or strand
displacement amplification (SDA) identified that DOP-PCR
had the highest error rate and SDA the lowest.
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Figure 3. Analysis of a single nucleotide polymorphism (SNP) marker in CYP1B1(rs0010012) by matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry. DOP-PCR = degenerate oligonucleotide-primed polymerase chain
reaction; LM-PCR = ligation-mediated polymerase chain reaction; SDA = strand displacement amplification.
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Table 2. Comparison of the three whole genome amplification (WGA) methods by using single nucleotide polymorphism 
(SNP) markers
SNP ID
Chromosome Concordance with genomic DNA (%)
allelic variation DOP-PCR LM-PCR SDA
rs0449856 A/T 100 100 100
rs0010012 G/C 100 100 100
rs2020874 G/T 100 100 100
rs2066479 A/G 100 100 100
rs4646422 A/G 100 100 100
rs8191246 A/G 100 100 100
(Tumor necrosis factor) C/T 100 100 100
(Transforming growth C/T 100 100 100
factor-beta)
rs605059 C/T 100 100 100
rs9340773 A/G 100 100 100
DOP-PCR = degenerate oligonucleotide-primed polymerase chain reaction; LM-PCR = ligation-mediated polymerase chain reaction; SDA = strand displacement
amplification.
Figure 4. Continued
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quantitative analysis with array-CGH and the results
were also compared with the result of original genomic
DNA. As shown in Table 3, loss of statistical signifi-
cance (false negative) and artificial addition of statistical
significance (false positive) were examined in the 46,XY,
46,XX,7q−, 46,XX,10q+ and SAOS2 cells when ampli-
fied by each WGA method (Figure 4 and Table 2).
According to results of array-CGH, amplification with
DOP-PCR tended to induce false negative results;
whereas both false negative and false positive amplifica-
tions were generated by all three WGA methods, espe-
cially in SAOS2 cancer cell lines, which were not
generated by the LM-PCR or SDA method in the 46,XY,
46,XX,7q− and 46,XX, 10q+ samples. Among these WGA
methods, amplified DNA products generated by LM-PCR
best reflect the original genomic DNA by analysis with
array-CGH.
All three WGA methods yielded sufficient DNA prod-
ucts for subsequent studies, such as microsatellite geno-
typing, SNP genotyping and array-CGH, when 10 ng of
genomic DNA were used as input. When time and ease
of procedure were considered, DOP-PCR and SDA were
much better than LM-PCR. Evaluation with 10 SNP
markers did not detect any mutation that had been intro-
duced during any of the three WGA methods. Geno-
typing with 25 microsatellite markers, however, revealed
that DOP-PCR generated the highest error rate at 33%,
with a similar tendency shown with results of array-CGH.
Therefore, our results suggested LM-PCR to be the most
reliable among the three WGA methods. When time and
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Figure 4. Comparison of microarray-based comparative genome hybridization between the original DNA and each amplified
DNA generated by degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR), ligation-mediated polymerase
chain reaction (LM-PCR) and strand displacement amplification (SDA) on specimens obtained from: (A) 46,XY; (B) 46,XX,7q−;
(C) 46,XX,10q+; and (D) SAOS2 osteosarcoma cell line. The karyotype of the reference DNA was 46,XX.
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ease of performance were considered, SDA was the easiest
method among these WGA methods. Previous reports
have reported success in amplification of trace amount
of genomic DNA (10 ng) by SDA; therefore, to test the
limitation of SDA, we further examined the efficiency of
SDA by using 1ng of genomic DNA as original input [14].
As evaluated with array-CGH, the genomic profile of
46,XX,10q+ after SDA with 1 ng input of genomic DNA
was identical to that of the original DNA (Figure 5).
Discussion
Geneticists have employed chromosome banding, various
types of fluorescence in situ hybridization, and conven-
tional CGH for genetic testing. With the advantages of
high resolution and high throughput, array CGH has
been advocated as the new cytogenetics [16]. Although
its performance, applications and data interpretation
remain to be validated in clinical applications, array-CGH
provides a whole genome analysis in one hybridization
reaction for detecting the changes of genomic DNA copy
number. To further extend the applications of array CGH
on any clinical specimens that may contain only nanogram
levels of genomic DNA, such as the cells isolated by laser-
capture microdissection [17], the addition of a reliable
WGA, however, appears indispensable. Vice versa, the
nature of array-CGH in whole-genome coverage lends
itself as the most critical method for validating the qual-
itative and quantitative performance of WGA [14].
Classified by the sequence length of DNA clones on
the slides, the three types of array-CGH used are those
with genomic clones (usually larger than 50,000 bp)
[18–21], cDNA clones (500 to 3,000 bp) [2,3,22], and
oligonucleotides (20 to 100 nucleotides) [23,24]. The
advantages and limitations of the three platforms have
been reviewed by Mantripragada et al [1], which will
not be discussed here. One critical factor in determin-
ing the reliability of microarray results is the signal-
to-noise ratio of microarray hybridization experiments
[1]. Signal-to-noise ratios are usually determined by the
efficiency of fluorescent labeling and detection and
the background reading of slide surface. In this study,
we used GMRCL Human 15K cDNA microarrays for
array-CGH analysis, in which the choices of slide and
spotting solution have been thoroughly verified [25].
The advantages of spotting cDNA clones on microar-
rays for genomic analysis include: (1) many cDNA clone
sets are available worldwide [3,22,25–28], and (2) cDNA
microarrays provide the same platform for doing par-
allel analysis of changes in DNA copy number and ex-
pression levels using the same set of genes [1]. This type
of parallel analysis has correlated with an upregulated
gene expression to 62% of amplified genes in human pri-
mary breast tumors [3] and has led to the identifica-
tion of genes important in the tumorigenesis of many
tumors [22,28,29]. On the other hand, because only
exons of genes and expressed sequence tags can be
analyzed with cDNA microarrays, the drawbacks of
Table 3. Comparison of microarray-based comparative genome hybridization between the original DNA and each amplified
DNA generated by degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR), ligation-mediated 
polymerase chain reaction (LM-PCR) and strand displacement amplification (SDA)
G-banding Original DNA (2 mg) DOP-PCR (10 ng) LM-PCR (10 ng) SDA (10 ng)
46,XY 46,XY 46,XY 46,XY 46,XY
46,XX,7q(−) 46,XX,7q(−) 46,XX 46,XX,7q(−) 46,XX,7q(−)
46,XX,10q(+) 46,XX,10q(+) 46,XX 46,XX,10q(+) 46,XX,10q(+)
SASO2 Amp: 1p, 1q, Amp: 1p, 1q, Amp:1p, 1q, 17q, 21 Amp: 1p, 1q,
17q, 21 3q, 6q Del: 8q 17q, 21, 6q
Del: 8q Del: 8q, 11p, 
16p, 19p
Amp = amplification; Del = deletion.
Original DNA 46,XX vs. 46,XX,10q+ 
10
Log (p value)
SDA amplicon 46,XX vs. 46,XX,10q(+) 
Log (p value)
5
5
0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X
−5
−10
10
0
−5
−10
Chromosome 
Chromosome 
Figure 5. Two examples of successful strand displacement
amplification (SDA) with 1 ng input of genomic DNA isolated
from amniocytes with karyotype 46,XX,10q+.
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using cDNA microarray for array CGH analysis include:
(1) an uneven distribution of measurement points
across the genome; and (2) the inability to analyze the
roles of gene regulation by promoters, introns, and
intergenic sequences in gene regulation.
When we used 10 ng of genomic DNA as input to
compare DOP-PCR, LM-PCR, and SDA, all three meth-
ods yielded sufficient DNA products for subsequent
molecular studies, such as microsatellite genotyping,
SNP genotyping and array-CGH. When time and ease of
procedure were considered, DOP-PCR and SDA were
much better than LM-PCR. Evaluation with 10 SNP
markers did not detect any mutation that had been
introduced during any of the three WGA methods. How-
ever, genotyping with 25 microsatellite markers revealed
that DOP-PCR generated the highest error rate (33%).
Collectively, with the evaluation with array-CGH, our
results suggested that LM-PCR is the most reliable
among the three WGA methods and SDA is the easiest
method to amplify genomic DNA.
In one reaction, SDA can be performed directly from
clinical specimens (whole blood, dried blood, buccal
cells, culture cells, buffy coats) without prior DNA iso-
lation [30] and can thereby be easily automated with a
robotic liquid handler. These attributes lend SDA a prom-
ising role in high-throughput processing. Two enzymes,
Bst and ϕ29 polymerases, have been used in SDA
[14,30,31], accounting for the priming event in SDA
reaction being propagated over very long distances
(> 20 Kb) in the genome. The error rate of ϕ29 DNA
polymerase (1 in 105 to 106 bp) [32] is much lower than
that of Taq polymerase (3 in 104 bp) [33]. The error rate
of Bst DNA polymerase (1 in 104) is higher than ϕ29
DNA polymerase; but for equal amplification of DNA
along the genome with SDA, Bst DNA polymerase was
shown to be better than ϕ29 polymerase in preserving
the original genomic dosage [14]. Finally, the disadvan-
tages of SDA are the higher costs for thiophosphate-
modified degenerate primers and Bst DNA polymerase
than the two PCR-based methods.
In conclusion, array-CGH provides the only method
to scan the whole genome for relative dosage alteration
in genomic DNA before and after WGA. Combined with
the high-fidelity WGA with LM-PCR method, array-CGH
can have many clinical applications, such as embryo
preimplantation genetic diagnosis, prenatal diagnosis
and cancer research.
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